Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New insights on how FMDV replicates
The team are now looking at how mutations in polyproteins could be used for producing attenuated vaccines.
Tiny protein could be the key to better vaccines  

Fresh insights on the replication processes of foot-and-mouth disease virus (FMDV) could pave the way for more effective vaccines, scientists say.

New findings published in PLOS Pathogens describe a tiny protein called 3B3, which is known to play a major role in the replication of FMDV. However, it also helps to increase the efficiency with which it can pack information into the genome, according to the Pirbright Institute and the University of Leeds.

FMD has a small amount of genetic material, so it has found ways to multiply its functions. During replication, the virus creates a string of proteins called polyproteins which are then cut up into their individual proteins. The research team discovered that 3B3 is key to directing the processing of the P3 polyprotein into its constituent parts.

Such methods are also used by other members of the picornavirus family, such as poliovirus, as well as non-picornaviruses.

Scientists say that systems such as these could be exploited to develop attenuated vaccines. The team are now looking at how mutations in polyproteins could be used for producing such vaccines.

Become a member or log in to add this story to your CPD history

Practices urged to audit neutering data

News Story 1
 RCVS Knowledge has called on vet practices to audit their post-operative neutering outcomes.

It follows the release of the 2024 NASAN benchmarking report, which collates data from neutering procedures performed on dogs, cats and rabbits.

The benchmarking report enables practices in the UK and Ireland to compare their post-operative outcomes to the national average. This includes the rate of patients lost to follow-up, which in 2024 increased to 23 per cent.

Anyone from the practice can submit the data using a free template. The deadline for next report is February 2026.

Visit the RCVS Knowledge website to complete an audit. 

Click here for more...
News Shorts
UK's BSE risk status downgraded

The WOAH has downgraded the UK's international risk status for BSE to 'negligible'.

Defra says that the UK's improved risk status recognises the reputation for having the highest standards for biosecurity. It adds that it demonstrates decades of rigorous animal control.

Outbreaks of Bovine Spongiform Encephalopathy, also known as mad cow disease, have previously resulted in bans on Britain's beef exports.

The UK's new status could lead to expanded trade and better confidence in British beef.

Christine Middlemiss, the UK's chief veterinary officer, said: "WOAH's recognition of the UK as negligible risk for BSE is a significant milestone and is a testament to the UK's strong biosecurity measures and the hard work and vigilance of farmers and livestock keepers across the country who have all played their part in managing the spread of this disease.